The essence of SK bioscience’s shared growth is the ‘Pursuit of Happiness for Stakeholders,’ which is the foundation of SK Group’s management. We seek to build trust through shared growth and cooperation and pursue productivity, corporate competitiveness, and innovation by identifying suppliers as primary stakeholders.
SK bioscience practices shared growth and cooperation by protecting partners’ rights from the partner selection phase to the conclusion of transactions in order to establish a fair trade order, believing that fair trade is at the heart of the shared growth strategy. We strictly adhere to the applicable laws and regulations, such as the Monopoly Regulation and Fair Trade Act, the Act on the Regulation of Terms and Conditions, the Act on Fair Transactions in Subcontracting, and the Act on Fair Labeling and Advertisement, which were enacted to promote free and fair competition and maintain appropriate trade order.
To expand the shared growth program in the future, we would like to operate desirable contract signing guidelines for shared growth between large and small enterprises. In signing the contract, we will discuss with the other party to decide on a delivery date suitable for regular practice. If we place an urgent order by requesting a shorter delivery time than usual, we will make sure we consult with our partners beforehand. Moreover, we will systematically prohibit unfair price reductions and reasonably determine or adjust subcontracting costs using the affordable unit price calculation methods. The methods reflect rising raw material prices, exchange rate fluctuations, and inflation factors.